 "Dottikon Exclusive Synthesis to invest $101 million in APIs facility")
Dottikon Exclusive Synthesis (ES) Group, which specialises in the area of hazardous reactions and manufactures active pharmaceutical ingredients (APIs) & fine chemicals, will invest more than CHF 100 million (about $101 million) in its development and production site in Dottikon (Aargau, Switzerland) over the coming two years. The major investments will consist of the creation of additional chemical process development and production capacities for APIs.
The new high-quality multi-tonne API drying capacities will be put into operation in the fourth quarter of 2016, while the additional multi-purpose production capacities for sophisticated chemistry will become operative in the first half of 2017. In order for the chemical process development and quality management to be ready for future growth, Dottikon ES will build a new four-storied laboratory and office building that will be ready in 2018.
Dottikon ES manufactures high-quality performance chemicals, intermediates and exclusive active pharmaceutical ingredients (APIs) for the global chemical and pharmaceutical industry. The company with its production site in Dottikon is specialised in hazardous reactions and is positioning itself as strategic development and manufacturing partner.
Its safety culture created over the last 100 years guides innovative use of hazardous reactions, low-temperature and high-pressure chemistry, as well as continuous processing. This shortens conventional chemical synthesis routes, increases yields & purities, and reduces waste. The versatile technology and equipment portfolio is used to design, develop and optimise chemical processes, and scale up from kilograms to multi-tonnes.
The new high-quality multi-tonne API drying capacities will be put into operation in the fourth quarter of 2016, while the additional multi-purpose production capacities for sophisticated chemistry will become operative in the first half of 2017. In order for the chemical process development and quality management to be ready for future growth, Dottikon ES will build a new four-storied laboratory and office building that will be ready in 2018.
Dottikon ES manufactures high-quality performance chemicals, intermediates and exclusive active pharmaceutical ingredients (APIs) for the global chemical and pharmaceutical industry. The company with its production site in Dottikon is specialised in hazardous reactions and is positioning itself as strategic development and manufacturing partner.
Its safety culture created over the last 100 years guides innovative use of hazardous reactions, low-temperature and high-pressure chemistry, as well as continuous processing. This shortens conventional chemical synthesis routes, increases yields & purities, and reduces waste. The versatile technology and equipment portfolio is used to design, develop and optimise chemical processes, and scale up from kilograms to multi-tonnes.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%